ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VTI Virotec Intl

12.50
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Virotec Intl LSE:VTI London Ordinary Share GB00B15PVR02 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 12.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Stmnt re Share Price Movement

04/04/2008 10:32am

UK Regulatory


RNS Number:6208R
Virotec International PLC
04 April 2008


Virotec International plc
4 April 2008

             VIROTEC INTERNATIONAL PLC ("Virotec" or "the Company")

           Share price movement and approach from Hydrodec Group PLC


The Board of Virotec have noted the sharp rise in the Company's ordinary share
price and the high level of turnover in their shares yesterday.

On 30 January 2008 the Company announced that it had received approaches that
might or might not lead to an offer for the Company. Discussions with one
particular party have been on-going since that date.

The Board was informed by Hydrodec Group PLC ("Hydrodec") on 3 April 2008 that
Hydrodec had bought 7.75 million Virotec ordinary shares at an average price of
7.85 pence per share. This purchase represents approximately 2.93 per cent. of
the issued share capital of Virotec.

Hydrodec also informed the Board of Virotec of its intention to make an all
share offer for the Company. On the basis of the share price of Hydrodec at the
close of business yesterday, the indicative offer would value each Virotec
ordinary share at approximately 12p per share. Hydrodec further notified the
Board of Virotec that it had received support from shareholders in Virotec,
representing in aggregate just below 30 per cent. of the issued share capital of
Virotec.

The Board of Virotec is consulting with its advisers and will make a further
announcement shortly.


For further information please contact:

Virotec International plc
Bruno Bamonte, Chief Financial Officer             +44 7730 663962
Angus Craig, Company Secretary                     +61 75573 3373

Arden Partners plc
Chris Hardie/Matthew Armitt                        +44 207 398 1630


                           VIROTEC INTERNATIONAL plc
                             Company Number 5796515
                                www.virotec.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
SPMGCGDSIDGGGIS

1 Year Virotec Chart

1 Year Virotec Chart

1 Month Virotec Chart

1 Month Virotec Chart